Telmisartan and Amlodipine Besylate Tablet 80/5mg
Telmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
JW Pharmaceutical Co., Ltd.
MFDS item code 201906173 · Approved 2019.08.29
This product's status changed to Expired on 2024.08.29. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of essential hypertension not controlled with monotherapy
Patients have difficulty controlling their blood pressure with either amlodipine or telmisartan monotherapy. This medication effectively lowers blood pressure to manage essential hypertension. It is used as a combination therapy when sufficient blood pressure control cannot be achieved with a single drug therapy, thereby helping to reduce cardiovascular risk and improve health. It is used in the treatment of essential hypertension.
The recommended dose of this medicine is 1 tablet once daily, taken with water regardless of meals. It is recommended to take it at the same time each day, if possible (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan) before starting this medicine; however, switching directly to this medicine may be considered if blood pressure is not adequately controlled with the individual components, as follows. - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. However, for patients with severe renal impairment, it is recommended to initiate treatment at a low dose and gradually increase the dose. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine dosage regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients Requiring Cautious Administration’). In older adults aged 75 years or over, amlodipine clearance is reduced; therefore, initiate treatment at a low dose and increase the dose gradually.
The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.
This medication can cause serious harm to the fetus, especially during the second and third trimesters of pregnancy; therefore, it should not be used by women who are pregnant or may become pregnant. Do not use in patients who are allergic to the active ingredient or similar components, those with severe liver impairment or hypotension, patients with serious heart problems, or diabetic patients with severely impaired kidney function. Patients with problems in the liver, heart, or kidneys or specific heart valve diseases should exercise special caution when using this medication, and dosage adjustment may be necessary. Common side effects such as dizziness or swelling may occur while taking this medication, and in severe cases, fainting or heart issues may arise, so consult your healthcare provider immediately if symptoms develop. Avoid using this medication during pregnancy, and if pregnancy is confirmed, discontinue immediately and switch to another safe therapy. Hypotension may occur if blood pressure is too low or if there is a shortage of fluids and salts in the body; caution is needed, and appropriate treatment is required if symptoms arise. There is a risk of elevated potassium levels in the blood; therefore, regular blood tests to monitor potassium levels should be conducted if taking potassium-rich medications or supplements. Patients with weak kidney function should periodically check kidney function and electrolyte status while taking this medication. This medication may interact with other antihypertensive agents or multiple medications, so inform your healthcare provider of any other drugs you are taking. Breastfeeding women are advised not to take this medication, and they should consult with a healthcare provider if they do. It is recommended not to use this medication in children due to insufficient evidence of its safety and efficacy. Elderly patients may be more sensitive to the medication, so starting with a lower dose and gradually increasing it is advisable. Overdose may result in hypotension, dizziness, cardiac arrhythmias, etc., so immediate medical attention is required.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light, so it should be stored in a dark container that does not allow light in. Additionally, it is important to store it at a temperature between 1 and 30 degrees Celsius to maintain its effectiveness.
It is a white and light gray, double convex, oval-shaped tablet.
30 tablets/PTP [30 tablets (10 tablets/Alu-Alu × 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Telmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
JW Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.